Cargando…

D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway

Endothelial dysfunction is involved in the pathophysiological processes of contrast media (CM)–induced acute kidney injury (CI-AKI) after vascular angiography or intervention. Previous study found that apolipoprotein A-I (apoA-I) mimetic peptide, D-4F, alleviates endothelial impairments via upregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yansong, Li, Wei, Qian, Mingming, Jiang, Ting, Guo, Ping, Du, Qian, Lin, Na, Xie, Xianwei, Wu, Zhiyong, Lin, Donghai, Liu, Donghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917283/
https://www.ncbi.nlm.nih.gov/pubmed/33658920
http://dx.doi.org/10.3389/fphar.2020.556074
_version_ 1783657665522565120
author Guo, Yansong
Li, Wei
Qian, Mingming
Jiang, Ting
Guo, Ping
Du, Qian
Lin, Na
Xie, Xianwei
Wu, Zhiyong
Lin, Donghai
Liu, Donghui
author_facet Guo, Yansong
Li, Wei
Qian, Mingming
Jiang, Ting
Guo, Ping
Du, Qian
Lin, Na
Xie, Xianwei
Wu, Zhiyong
Lin, Donghai
Liu, Donghui
author_sort Guo, Yansong
collection PubMed
description Endothelial dysfunction is involved in the pathophysiological processes of contrast media (CM)–induced acute kidney injury (CI-AKI) after vascular angiography or intervention. Previous study found that apolipoprotein A-I (apoA-I) mimetic peptide, D-4F, alleviates endothelial impairments via upregulating heme oxygenase-1 (HO-1) expression and scavenging excessively generated reactive oxygen species (ROS). However, whether D-4F could ameliorate oxidative injuries in endothelial cells through suppressing ROS production remains unclear. In this study, a representative nonionic iodinated CM, iodixanol, was chosen for the in vitro and in vivo studies. Endothelial cell viability was assayed using micrographs, lactate dehydrogenase (LDH) activity, and cell counting kit-8 (CCK-8). Apoptosis was detected using flow cytometry analysis and caspase-3 activation. Endothelial inflammation was tested using monocyte adhesion assay and adhesion molecule expression. ROS production was detected by measuring the formation of lipid peroxidation malondialdehyde (MDA) through the thiobarbituric acid reactive substance (TBARS) assay. Peroxynitrite (ONOO⁻) formation was tested using the 3-nitrotyrosine ELISA kit. Iodixanol impaired cell viability, promoted vascular cell adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-1) expression, and induced cell apoptosis in human umbilical vein endothelial cells (HUVECs). However, D-4F mitigated these injuries. Furthermore, iodixanol induced the phosphorylation of protein kinase C (PKC) beta II, p47, Rac1, and endothelial nitric oxide synthase (eNOS) at Thr495, which elicited ROS release and ONOO⁻ generation. D-4F inhibited NADPH oxidase (NOX) activation, ROS production, and ONOO⁻ formation via the AMP-activated protein kinase (AMPK)/PKC pathway. Additionally, after an intravascular injection of iodixanol in Sprague Dawley rats, iodixanol induced a remarkable inflammatory response in arterial endothelial cells, although significant apoptosis and morphological changes were not observed. D-4F alleviated the vessel inflammation resulting from iodixanol in vivo. Collectively, besides scavenging ROS, D-4F could also suppress ROS production and ONOO⁻ formation through the AMPK/PKC pathway, which ameliorated oxidative injuries in endothelial cells. Hence, D-4F might serve as a potential agent in preventing CI-AKI.
format Online
Article
Text
id pubmed-7917283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79172832021-03-02 D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway Guo, Yansong Li, Wei Qian, Mingming Jiang, Ting Guo, Ping Du, Qian Lin, Na Xie, Xianwei Wu, Zhiyong Lin, Donghai Liu, Donghui Front Pharmacol Pharmacology Endothelial dysfunction is involved in the pathophysiological processes of contrast media (CM)–induced acute kidney injury (CI-AKI) after vascular angiography or intervention. Previous study found that apolipoprotein A-I (apoA-I) mimetic peptide, D-4F, alleviates endothelial impairments via upregulating heme oxygenase-1 (HO-1) expression and scavenging excessively generated reactive oxygen species (ROS). However, whether D-4F could ameliorate oxidative injuries in endothelial cells through suppressing ROS production remains unclear. In this study, a representative nonionic iodinated CM, iodixanol, was chosen for the in vitro and in vivo studies. Endothelial cell viability was assayed using micrographs, lactate dehydrogenase (LDH) activity, and cell counting kit-8 (CCK-8). Apoptosis was detected using flow cytometry analysis and caspase-3 activation. Endothelial inflammation was tested using monocyte adhesion assay and adhesion molecule expression. ROS production was detected by measuring the formation of lipid peroxidation malondialdehyde (MDA) through the thiobarbituric acid reactive substance (TBARS) assay. Peroxynitrite (ONOO⁻) formation was tested using the 3-nitrotyrosine ELISA kit. Iodixanol impaired cell viability, promoted vascular cell adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-1) expression, and induced cell apoptosis in human umbilical vein endothelial cells (HUVECs). However, D-4F mitigated these injuries. Furthermore, iodixanol induced the phosphorylation of protein kinase C (PKC) beta II, p47, Rac1, and endothelial nitric oxide synthase (eNOS) at Thr495, which elicited ROS release and ONOO⁻ generation. D-4F inhibited NADPH oxidase (NOX) activation, ROS production, and ONOO⁻ formation via the AMP-activated protein kinase (AMPK)/PKC pathway. Additionally, after an intravascular injection of iodixanol in Sprague Dawley rats, iodixanol induced a remarkable inflammatory response in arterial endothelial cells, although significant apoptosis and morphological changes were not observed. D-4F alleviated the vessel inflammation resulting from iodixanol in vivo. Collectively, besides scavenging ROS, D-4F could also suppress ROS production and ONOO⁻ formation through the AMPK/PKC pathway, which ameliorated oxidative injuries in endothelial cells. Hence, D-4F might serve as a potential agent in preventing CI-AKI. Frontiers Media S.A. 2021-02-15 /pmc/articles/PMC7917283/ /pubmed/33658920 http://dx.doi.org/10.3389/fphar.2020.556074 Text en Copyright © 2021 Guo, Li, Qian, Jiang, Guo, Du, Lin, Xie, Wu, Lin and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Guo, Yansong
Li, Wei
Qian, Mingming
Jiang, Ting
Guo, Ping
Du, Qian
Lin, Na
Xie, Xianwei
Wu, Zhiyong
Lin, Donghai
Liu, Donghui
D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title_full D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title_fullStr D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title_full_unstemmed D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title_short D-4F Ameliorates Contrast Media–Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway
title_sort d-4f ameliorates contrast media–induced oxidative injuries in endothelial cells via the ampk/pkc pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917283/
https://www.ncbi.nlm.nih.gov/pubmed/33658920
http://dx.doi.org/10.3389/fphar.2020.556074
work_keys_str_mv AT guoyansong d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT liwei d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT qianmingming d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT jiangting d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT guoping d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT duqian d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT linna d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT xiexianwei d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT wuzhiyong d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT lindonghai d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway
AT liudonghui d4famelioratescontrastmediainducedoxidativeinjuriesinendothelialcellsviatheampkpkcpathway